Sarcoidosis: Insights into the Targets of Cellular Immunity

However, the authors acknowledged in their discussion that, “We could not demonstrate a vimentin-specific response in all sarcoidosis patients. In this respect, it is also important to note that there was no clinical difference (e.g., radiological stage of disease at presentation, age of patient, need for subsequent immunosuppression therapy) between vimentin responders and non-responders.”

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

Reference

Eberhardt C, Thillai M, Parker R, et al. Proteomic analysis of Kveim Reagent identifies targets of cellular immunity in sarcoidosis. PLoS One. 2017 Jan 23;12(1):e0170285. doi: 10.1371/journal.pone.0170285. eCollection 2017.

https://www.ncbi.nlm.nih.gov/pubmed/28114394

An expert discussed the screening and treatment of sarcoidosis and drug-induced sarcoidosis-like reactions during the 2021 ACR State-of-the-Art Clinical Symposium.

People with autoimmune connective tissue diseases produce antibodies against nuclear antigens up to 10 years before they develop clinical features. Anti-nuclear antibodies (ANAs) are also very common, and a small percentage of ANA-positive patients progress to clinical autoimmunity. The question: Is there a reliable way to screen at-risk patients before they develop active autoimmunity and…

Sarcoidosis and IgG4-related disease (IgG4-RD) are both immune-mediated, often multi-organ, diseases of uncertain etiology capable of presenting with diverse clinical manifestations. Many clinical features are common to both conditions, including hypergammaglobulinemia, the ability to form inflammatory masses and involvement of the lymph nodes, lacrimal glands, salivary glands, meninges and lungs. Although imaging modalities, such as…

Two patients with psoriatic arthritis treated with TNF-alpha inhibitor therapy develop the multisystem disease

Sarcoidosis in the Spotlight: Screening, Treatment & More Insights into Sarcoidosis

Interferon Score Predicts AI-CTDs

Case Report: Sarcoidosis in Patient with History of IgG4-Related Disease

Fellow’s Forum Case Report: New Sarcoidosis Cases in Patients Treated with Tumor Necrosis Factor–Alpha Inhibitors

Related Articles